Exagen Inc. (NASDAQ:XGN – Get Free Report) saw a significant decline in short interest in April. As of April 15th, there was short interest totalling 11,900 shares, a decline of 42.0% from the March 31st total of 20,500 shares. Currently, 0.2% of the shares of the company are sold short. Based on an average daily volume of 38,200 shares, the days-to-cover ratio is presently 0.3 days.
Exagen Price Performance
Exagen stock opened at $1.41 on Friday. Exagen has a 52 week low of $1.30 and a 52 week high of $3.92. The business has a 50-day simple moving average of $1.68 and a 200 day simple moving average of $1.76. The company has a quick ratio of 4.02, a current ratio of 4.02 and a debt-to-equity ratio of 0.85. The stock has a market cap of $24.34 million, a price-to-earnings ratio of -1.05 and a beta of 1.19.
Exagen (NASDAQ:XGN – Get Free Report) last posted its earnings results on Monday, March 18th. The company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.41) by ($0.02). Exagen had a negative return on equity of 80.28% and a negative net margin of 45.08%. The business had revenue of $13.77 million for the quarter, compared to analysts’ expectations of $11.43 million. During the same quarter in the previous year, the firm earned ($0.58) earnings per share. On average, research analysts forecast that Exagen will post -1.46 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Exagen
About Exagen
Exagen Inc develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
Read More
- Five stocks we like better than Exagen
- 3 REITs to Buy and Hold for the Long Term
- MarketBeat Week in Review – 4/22 – 4/26
- Why Are Stock Sectors Important to Successful Investing?
- 3 Stocks Leading the U.S. Agriculture Comeback
- Transportation Stocks Investing
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Exagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exagen and related companies with MarketBeat.com's FREE daily email newsletter.